Differential (Click to cross reference) advances in neurology adverse drug reaction aggression agitation Alzheimer's disease Alzheimer's disease, treatment of anticonvulsants antidepressant anxiety behavior behavior, combative behavioral disorder benzodiazepine buspirone Call-Fleming syndrome carbamazepine cerebral ischemia cerebrovascular accident citalopram coumarin delusion depression depression, treatment of dilantin drug induced neurologic disorders drug interactions efficacy enzyme inhibition fluoxetine fluvoxamine hallucination haloperidol headache headache, drug induced headache, severe headache, thunderclap L-dopa movement disorder, drug induced MRI, abnormal neuroleptic Parkinson disease Parkinson disease, drug induced Parkinsonism syndrome paroxetine psychosis psychotic behavior safety selective serotonin reuptake inhibitors serotonin agonist serotonin norepinephrine reuptake inhibitors sertraline sumatriptan trazodone treatment of neurologic disorder tricyclic antidepressant triptans vasospasm, cerebral venlafaxine

Showing articles 0 to 7 of 7 A Randomized, Double-Blind, Placebo-Controlled Trial of Antidepressants in Parkinson Disease Neurol 78:1229-1236, Richard,I.H.,et al, 2012 Short-Term Paroxetine Treatment Does Not Alter the Motor Response to Levodopa in PD Neurol 64:1797-1798, Chung,K.A.,et al, 2005 Cerebral Vasoconstriction and Stroke After Use of Serotonergic Drugs Neurol 58:130-133, Singhal,A.B.,et al, 2002 Depression in Parkinson's Disease BMJ 320:1287-1288, Allain,H.,et al, 2000 Clinical Features and Pharmacologic Treatment of Behavioral Symptoms of Alzheimer's Disease Neurol 48 (Suppl 6) :S17-S24997., Borson,S.&Raskind,M.A., 1997 A Survey of Antidepressant Drug Use in Parkinson's Disease Neurol 49:1168-1170, Richard,I.H.,et al, 1997 Pharmacogenetics and Drug Metabolism of Newer Antidepressant Agents J Clin Psychiatry 55:38-45, DeVane,C.L., 1994 Showing articles 0 to 7 of 7